DrugPatentWatch Database Preview
TOFRANIL-PM Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Tofranil-pm, and what generic alternatives are available?
The generic ingredient in TOFRANIL-PM is imipramine pamoate. There are thirty-four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the imipramine pamoate profile page.
Summary for TOFRANIL-PM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 34 |
| Clinical Trials: | 5 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TOFRANIL-PM at DailyMed |
US Patents and Regulatory Information for TOFRANIL-PM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Specgx Llc | TOFRANIL-PM | imipramine pamoate | CAPSULE;ORAL | 017090-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
